Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news
2022 December Dec 23

Read more
EU: Marketing Authorization Holders involved in GMP, GCP and GVP inspections coordinated by EMA
2022 December Dec 19

EU: Marketing Authorization Holders involved in GMP, GCP and GVP inspections coordinated by EMA

Read more
EU: meeting highlights from the CHMP
2022 December Dec 16

EU: meeting highlights from the CHMP

Read more
Australia: Pharmacovigilance Inspection Program
2022 December Dec 05

Australia: Pharmacovigilance Inspection Program

Read more
Clinical Trials Information System (CTIS)
2022 December Dec 02

Clinical Trials Information System (CTIS)

Read more
Austria: FAQ Pharmacovigilance – 22-Nov-2022
2022 November Nov 28

Austria: FAQ Pharmacovigilance – 22-Nov-2022

Read more
Benfluorex: assessment of the follow-up of cases of pulmonary arterial hypertension
2022 November Nov 25

Benfluorex: assessment of the follow-up of cases of pulmonary arterial hypertension

https://ansm.sante.fr/actualites/benfluorex-bilan-du-suivi-des-cas-dhypertension-arterielle-pulmonaire

Read more
EU : List of centrally authorised products requiring a notification of a change for update of annexes
2022 November Nov 18

EU : List of centrally authorised products requiring a notification of a change for update of annexes

Read more
Germany: Compassionate Use Programmes_28-Oct-2022
2022 November Nov 14

Germany: Compassionate Use Programmes_28-Oct-2022

Read more
Minutes of the PRAC – 07-Nov-2022
2022 November Nov 10

Minutes of the PRAC – 07-Nov-2022

Read more
  • « Previous
  • Next »

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • Drug clinical trials: the CTIS portal becomes the sole entry point for new requests as of the 31st of January 2023
  • Work Plan 2023 of the Pharmacovigilance Risk Assessment Committee (PRAC)
  • Welcome to the team!
Copyright © 2018 - Pharmya - Legal terms - Quality Policy